3 -Methoxy- 4 -hydroxyphenylethylene glycol in human cerebrospinal fluid.
D002849:Chromatography, Gas; D003863:Depression / Q000134:cerebrospinal fluid / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004314:Down Syndrome / Q000134:cerebrospinal fluid / Q000188:drug therapy; D004987:Ethers / Q000134:cerebrospinal fluid; D006018:Glycols / Q000134:cerebrospinal fluid*; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000188:drug therapy; D010636:Phenols / Q000134:cerebrospinal fluid; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D011339:Probenecid / Q000627:therapeutic use
D004987:Ethers; D006018:Glycols; D010636:Phenols; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D011339:Probenecid